325
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Comparison of High Flow Nasal Therapy with Non-Invasive Ventilation and Conventional Oxygen Therapy for Acute Hypercapnic Respiratory Failure: A Meta-Analysis of Randomized Controlled Trials

ORCID Icon, , ORCID Icon &
Pages 955-973 | Received 18 Mar 2023, Accepted 06 May 2023, Published online: 22 May 2023

References

  • Comellini V, Pacilli AMG, Nava S. Benefits of non‐invasive ventilation in acute hypercapnic respiratory failure. Respirology. 2019;24(4):308–317. doi:10.1111/resp.13469
  • Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J. 2003;22(Supplement47):3s–14s. doi:10.1183/09031936.03.00038503
  • Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. doi:10.1183/13993003.02426-2016
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
  • Nava S, Navalesi P, Gregoretti C. Interfaces and humidification for noninvasive mechanical ventilation. Respir Care. 2009;54(1):71–84.
  • Nishimura M. High-flow Nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529–541. doi:10.4187/respcare.04577
  • Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022;59(4):2101574. doi:10.1183/13993003.01574-2021
  • Bräunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth H, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration. 2013;85(4):319–325. doi:10.1159/000342027
  • Bräunlich J, Köhler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077–1085.
  • Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20(4):126–131. doi:10.1016/j.aucc.2007.08.001
  • Pisani L, Fasano L, Corcione N, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax. 2017;72(4):373–375. doi:10.1136/thoraxjnl-2016-209673
  • Bae S, Han M, Kim C, et al. High-flow nasal cannula oxygen therapy can be effective for patients in acute hypoxemic respiratory failure with hypercapnia: a retrospective, propensity score-matched cohort study. J Korean Med Sci. 2020;35(10). doi:10.3346/jkms.2020.35.e67
  • Cortegiani A, Longhini F, Madotto F, et al. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 2020;24(1). doi:10.1186/s13054-020-03409-0
  • Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J. 2018;12(6):2046–2056. doi:10.1111/crj.12772
  • Gottlieb J, Capetian P, Hamsen U, et al. German S3 guideline: oxygen therapy in the acute care of adult patients. Respiration. 2022;101(2):214–252. doi:10.1159/000520294
  • Xu Z, Zhu L, Zhan J, Liu L. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review. Eur J Med Res. 2021;26(1). doi:10.1186/s40001-021-00587-7
  • Liu W, Zhu M, Xia L, et al. Transnasal high-flow oxygen therapy versus noninvasive positive pressure ventilation in the treatment of COPD with type II respiratory failure: a meta-analysis. Comput Math Methods Med. 2022;2022:1–10.
  • Huang Y, Lei W, Zhang W, Huang J, Trisolini R. High-flow nasal cannula in hypercapnic respiratory failure: a systematic review and meta-analysis. Can Respir J. 2020;2020:1–13. doi:10.1155/2020/7406457
  • Alnajada AA, Blackwood B, Mobrad A, Akhtar A, Pavlov I, Shyamsundar M. High flow nasal oxygen for acute type two respiratory failure: a systematic review. F1000Research. 2021;10:482. doi:10.12688/f1000research.52885.2
  • Ovtcharenko N, Ho E, Alhazzani W, et al. High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials. Crit Care. 2022;26(1). doi:10.1186/s13054-022-04218-3
  • Sklar MC, Dres M, Rittayamai N, et al. High-flow nasal oxygen versus noninvasive ventilation in adult patients with cystic fibrosis: a randomized crossover physiological study. Ann Intensive Care. 2018;8(1). doi:10.1186/s13613-018-0432-4
  • Rezaei A, Fakharian A, Ghorbani F, Idani E, Abedini A, Jamaati H. Comparison of high‐flow oxygenation with noninvasive ventilation in COPD exacerbation: a crossover clinical trial. Clin Respir J. 2021;15(4):420–429. doi:10.1111/crj.13315
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. doi:10.1371/journal.pmed.1003583
  • Doshi PB, Whittle JS, Dungan G, et al. The ventilatory effect of high velocity nasal insufflation compared to non-invasive positive-pressure ventilation in the treatment of hypercapneic respiratory failure: a subgroup analysis. Heart Lung. 2020;49(5):610–615. doi:10.1016/j.hrtlng.2020.03.008
  • Papachatzakis Y, Nikolaidis PT, Kontogiannis S, Trakada G. High-flow oxygen through nasal cannula vs non-invasive ventilation in hypercapnic respiratory failure: a randomized clinical trial. Int J Environ Res Public Health. 2020;17(16):5994. doi:10.3390/ijerph17165994
  • Tan D, Walline JH, Ling B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care. 2020;24(1). doi:10.1186/s13054-020-03214-9
  • Jing G, Li J, Hao D, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health. 2019;42(3):217–225. doi:10.1002/nur.21942
  • Xia J, Gu S, Lei W, et al. High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial. Crit Care. 2022;26(1). doi:10.1186/s13054-022-03973-7
  • Cong L, Zhou L, Liu H, Wang J. Outcomes of high-flow nasal cannula versus non-invasive positive pressure ventilation for patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Clin Exp Med. 2019;12(8):10863–10867.
  • Wang JJ, Li Q. Randomized controlled study of HFNC and NPPV in the treatment of AECOPD combined with type II respiratory failure. Chin J Integr Med. 2019;2019:1–15.
  • Yu Z. Efficacy and safety of humidified high flow nasal cannula in chronic obstructive pulmonary disease complicated with type 2 respiratory failure patients after extubation: a randomized controlled trial. Acad J Second Mil Med Univ. 2019;2019:989–994.
  • Li X, Tang X, Wang R, et al. High-flow nasal cannula for chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure: a randomized, controlled trial. Int J Chron Obstruct Pulmon Dis. 2020;15:3051–3061. doi:10.2147/COPD.S283020
  • Frat JP, Coudroy R, Thille AW. Non‐invasive ventilation or high‐flow oxygen therapy: when to choose one over the other? Respirology. 2019;24(8):724–731. doi:10.1111/resp.13435
  • Fraser JF, Spooner AJ, Dunster KR, Anstey CM, Corley A. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016;71(8):759–761. doi:10.1136/thoraxjnl-2015-207962
  • Bräunlich J, Dellweg D, Bastian A, et al. Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:1411–1421. doi:10.2147/COPD.S206111
  • Venkatesan P. GOLD COPD report: 2023 update. Lancet Respira Med. 2023;11(1):18. doi:10.1016/S2213-2600(22)00494-5